Conn. Agencies Regs. § 21a-408-12a

Current through June 15, 2024

Section 21a-408-12a - Additional Debilitating Medical Conditions

In accordance with the procedures set forth in section 21a-408a-12 of the Regulations of Connecticut State Agencies, the following medical conditions, medical treatments or diseases shall be added to the list of debilitating medical conditions:

(a) For patients eighteen years of age or older:

(1) Sickle cell disease;

(2) Post laminectomy syndrome with chronic radiculopathy;

(3) Severe psoriasis and psoriatic arthritis;

(4) Amyotrophic lateral sclerosis;

(5) Ulcerative colitis;

(6) Complex regional pain syndrome, Type 1 and Type II;

(7) Spasticity or Neuropathic Pain Associated with Fibromyalgia;

(8) Severe Rheumatoid Arthritis;

(9) Post Herpetic Neuralgia;

(10) Muscular Dystrophy;

(11) Hydrocephalus with Intractable Headache;

(12) Intractable Headache Syndromes;

(13) Neuropathic Facial Pain;

(14) Osteogenesis Imperfecta;

(15) Chronic Neuropathic Pain Associated with Degenerative Spinal Disorders;

(16) Interstitial Cystitis;

(17) Intractable Neuropathic Pain that is unresponsive to standard medical treatments;

(18) Median Arcuate Ligament Syndrome;

(19) Tourette Syndrome;

(20) Vulvodynia and vulvar burning;

(21) Chronic Pain of at least 6 months duration associated with a specified underlying chronic condition refractory to other treatment intervention;

(22) Ehlers-Danlos Syndrome associated with Chronic Pain; and

(23) Chronic Pancreatitis.

(b) For patients under eighteen years of age:

(1) Muscular Dystrophy;

(2) Osteogenesis Imperfecta;

(3) Intractable Neuropathic Pain that is unresponsive to standard medical treatments;

(4) Tourette Syndrome for patients who have failed standard medical treatment; and

(5) Chronic Pancreatitis for patients whose pain is recalcitrant to standard medical management.

Conn. Agencies Regs. § 21a-408-12a

Effective March 4, 2016; amended 8/28/2018; amended 4/30/2019; Amended 10/23/2019; Amended 6/3/2020; amended 3/24/2021